Co-Authors
This is a "connection" page, showing publications co-authored by Jesús Villar and Arthur Slutsky.
Connection Strength
1.682
-
Early Paralytic Agents for ARDS? Yes, No, and Sometimes. N Engl J Med. 2019 05 23; 380(21):2061-2063.
Score: 0.824
-
What have we learned ventilating COVID-19 patients? Intensive Care Med. 2020 12; 46(12):2458-2460.
Score: 0.227
-
Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial. Trials. 2020 Aug 16; 21(1):717.
Score: 0.224
-
Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Transl Med. 2017 Jul; 5(14):283.
Score: 0.181
-
Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2021 Jan; 47(1):144-146.
Score: 0.058
-
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 10 06; 324(13):1330-1341.
Score: 0.057
-
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials. Trials. 2020 Aug 24; 21(1):734.
Score: 0.056
-
Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020 12; 46(12):2200-2211.
Score: 0.056